Published in Haemostasis on January 01, 1990
Efficacy and safety of intravenous midazolam and ketamine as sedation for therapeutic and diagnostic procedures in children. Pediatrics (1997) 15.08
Impairment of insulin secretion in man by nifedipine. Eur J Clin Pharmacol (1980) 2.22
The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia (2000) 1.86
Oxidative stress and insulin action: is there a relationship? Diabetologia (1996) 1.86
Abdominal volume contribution to tidal volume as an early indicator of respiratory impairment in Duchenne muscular dystrophy. Eur Respir J (2009) 1.65
Silver nitrate is superior to talc slurry in producing pleurodesis in rabbits. Chest (2000) 1.59
The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res (2005) 1.50
Elevated plasma fatty acid concentrations prolong cardiac repolarization in healthy subjects. Am J Clin Nutr (2001) 1.49
Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost (2004) 1.48
Association of body weight with sexual function in women. Int J Impot Res (2007) 1.43
Pregnancy as environmental factor precipitating IDDM. Diabetes Care (1989) 1.43
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA (1999) 1.42
Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost (1990) 1.40
Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia (2002) 1.38
Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res (2010) 1.38
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis (2010) 1.36
Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation (2000) 1.27
Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest (2001) 1.23
Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. Eur Respir J (1998) 1.20
Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitus. Diabet Med (2009) 1.18
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. Ann Oncol (2006) 1.16
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol (1998) 1.15
Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab (1991) 1.15
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. Ann Oncol (2008) 1.14
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab (2011) 1.14
Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? Ann Intern Med (1990) 1.14
Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr (1993) 1.14
Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Obes Metab (2011) 1.14
Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics. Diabet Med (2010) 1.13
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care (1991) 1.12
Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res (2005) 1.11
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer (2004) 1.10
Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care (2000) 1.10
Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Invest (2004) 1.09
Impaired glucose metabolism in heroin and methadone users. Horm Metab Res (1987) 1.07
Acute hyperglycemia and autonomic function. Diabetes Care (2001) 1.07
Influence of acetylsalicylic acid on glucose turnover in normal man. Diabete Metab (1982) 1.06
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol (1995) 1.06
Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest (2013) 1.04
Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia (2001) 1.02
Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism (1994) 1.02
Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism (1983) 1.01
The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis (2004) 1.01
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol (1993) 1.00
The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia (1978) 0.99
Effect of metformin on food intake in obese subjects. Eur J Clin Invest (1998) 0.99
Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. Diabetologia (1998) 0.98
Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int (1992) 0.98
Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol (1994) 0.98
High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia (2001) 0.98
Resting metabolic rate and respiratory quotient in human longevity. J Clin Endocrinol Metab (2004) 0.97
Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care (1993) 0.96
Obesity and sexual dysfunction, male and female. Int J Impot Res (2008) 0.95
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med (1992) 0.95
Respiratory pattern in an adult population of dystrophic patients. J Neurol Sci (2011) 0.95
Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res (2010) 0.94
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int (1994) 0.93
Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia (1986) 0.93
Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res (2006) 0.93
Defective methionine metabolism in cirrhosis: relation to severity of liver disease. Hepatology (1992) 0.93
Metabolic control may influence the increased superoxide generation in diabetic serum. Diabet Med (1991) 0.92
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. Diabetologia (1993) 0.91
Oxidative stress in the metabolic syndrome. J Endocrinol Invest (2006) 0.90
Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity. J Endocrinol Invest (2002) 0.90
Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial. Diabetes Obes Metab (2011) 0.90
Lacidipine inhibits the activation of the transcription factor NF-kappaB and the expression of adhesion molecules induced by pro-oxidant signals on endothelial cells. J Hypertens (1997) 0.89
Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest (1999) 0.89
A novel approach combining the Calgary Biofilm Device and Phenotype MicroArray for the characterization of the chemical sensitivity of bacterial biofilms. Biofouling (2012) 0.88
Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants. Ann Intern Med (1995) 0.88
Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia (1988) 0.88
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. Diabetologia (1982) 0.87
Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients. Diabetologia (2004) 0.87
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metabolism (1991) 0.87
Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res (2006) 0.87
Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care (1992) 0.87
Acetyl-L-carnitine for symptomatic diabetic neuropathy. Diabetologia (1995) 0.87
Obesity, the metabolic syndrome, and sexual dysfunction in men. Clin Pharmacol Ther (2011) 0.87
Morphine, opioid peptides, and pancreatic islet function. Diabetes Care (1984) 0.86
Acute inflammatory response secondary to intrapleural administration of two types of talc. Eur Respir J (2009) 0.86
Pharmacokinetic-pharmacodynamic relationships of Acarbose. Clin Pharmacokinet (1996) 0.86
GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Curr Med Res Opin (2011) 0.86
Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J Clin Endocrinol Metab (2001) 0.86
Lifestyle and metabolic approaches to maximizing erectile and vascular health. Int J Impot Res (2011) 0.86